X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (625) 625
Publication (48) 48
Book Review (11) 11
Newsletter (11) 11
Book Chapter (7) 7
Dissertation (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (498) 498
male (326) 326
pharmacology & pharmacy (289) 289
erythromycin (283) 283
female (270) 270
adult (261) 261
erythromycin breath test (244) 244
middle aged (172) 172
cytochrome p-450 cyp3a (160) 160
cytochrome p-450 enzyme system - metabolism (153) 153
index medicus (148) 148
aged (108) 108
pharmacokinetics (108) 108
metabolism (100) 100
breath tests (96) 96
animals (93) 93
drug interactions (79) 79
administration, oral (65) 65
erythromycin - therapeutic use (64) 64
adolescent (59) 59
p-glycoprotein (59) 59
midazolam (56) 56
gastroenterology & hepatology (54) 54
area under curve (53) 53
erythromycin - pharmacology (53) 53
anti-bacterial agents - therapeutic use (51) 51
aryl hydrocarbon hydroxylases (50) 50
cross-over studies (49) 49
erythromycin - pharmacokinetics (48) 48
liver - enzymology (48) 48
mixed function oxygenases - metabolism (47) 47
cyclosporine (46) 46
midazolam - pharmacokinetics (45) 45
gastric emptying - drug effects (43) 43
in-vivo (43) 43
oxidoreductases, n-demethylating - metabolism (43) 43
cyp3a4 (42) 42
cytochrome p-450 (42) 42
dose-response relationship, drug (42) 42
enzymes (42) 42
research (42) 42
cyp3a (41) 41
cytochrome p-450 enzyme inhibitors (41) 41
cytochrome p-450 enzyme system - genetics (41) 41
drug-metabolism (40) 40
gastric emptying (40) 40
identification (40) 40
double-blind method (39) 39
erythromycin - administration & dosage (39) 39
oncology (38) 38
clearance (37) 37
clarithromycin (35) 35
time factors (35) 35
azithromycin (34) 34
drug-interactions (34) 34
health aspects (34) 34
phenotype (34) 34
pneumonia (34) 34
treatment outcome (34) 34
liver - metabolism (33) 33
prospective studies (33) 33
enzyme inhibitors - pharmacology (32) 32
human liver-microsomes (32) 32
in-vitro (32) 32
respiratory system (32) 32
toxicology (32) 32
antibiotics (31) 31
care and treatment (31) 31
cytochrome p-450 cyp3a - metabolism (31) 31
expression (31) 31
medicine & public health (31) 31
breath tests - methods (30) 30
child (30) 30
gastroparesis (30) 30
metabolic clearance rate (30) 30
physiological aspects (30) 30
reference values (30) 30
aged, 80 and over (29) 29
breath test (29) 29
cytochrome p450 (29) 29
drug metabolism (29) 29
erythromycin - metabolism (29) 29
rats (29) 29
analysis (28) 28
human-liver (28) 28
motility (28) 28
anti-bacterial agents - pharmacology (27) 27
midazolam - blood (26) 26
biological availability (25) 25
carbon radioisotopes (25) 25
pediatrics (25) 25
risk factors (25) 25
drug therapy (24) 24
genotype (24) 24
liver (24) 24
microsomes, liver - enzymology (24) 24
small-bowel (24) 24
therapy (24) 24
child, preschool (23) 23
cyp3a activity (23) 23
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 2013, Volume 19, Issue 27, pp. 4380 - 4385
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 01/2012, Volume 69, Issue 1, pp. 125 - 135
Background Docetaxel has marked inter-patient PK variability, and metabolic phenotypic probes may enable individualised dosing. This is the first report... 
Antipyrine | In vivo probes | Erythromycin breath test | Docetaxel | ADVANCED CANCER | ELIMINATION | TOXICITY | HEPATIC-FUNCTION | 3A ACTIVITY | ONCOLOGY | LIVER-FUNCTION | ERYTHROMYCIN | PHARMACOLOGY & PHARMACY | ANTICANCER DRUGS | BODY-SURFACE-AREA | PHASE-I
Journal Article
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 08/2009, Volume 68, Issue 2, pp. 226 - 237
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • The response to gefitinib is variable and could be explained partly by the interindividual variability in gefitinib... 
liver CYP3A4 | gefitinib | induction | phenytoin | P‐gp | P-gp | Gefitinib | Induction | Phenytoin | Liver CYP3A4 | Polymerase chain reaction | Liquid chromatography | Erythromycin | Cytochrome P-450 | Drug Metabolism
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 05/2006, Volume 79, Issue 5, pp. 440 - 448
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 1/2012, Volume 69, Issue 1, pp. 125 - 135
Docetaxel has marked inter-patient PK variability, and metabolic phenotypic probes may enable individualised dosing. This is the first report directly... 
Medicine & Public Health | Erythromycin breath test | Docetaxel | Antipyrine | Oncology | Cancer Research | In vivo probes | Pharmacology/Toxicology
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 01/2012, Volume 69, Issue 1, p. 125
Docetaxel has marked inter-patient PK variability, and metabolic phenotypic probes may enable individualised dosing. This is the first report directly... 
Care and treatment | Oncology, Experimental | Cytochrome P-450 | Docetaxel | Study and teaching | Erythromycin | Nonsteroidal anti-inflammatory drugs | Research | Atmospheric carbon dioxide | Cancer
Journal Article